Insider · CIK 0001442372

Sabba Stephen L

Reports to the SEC for 2 companies · SYOSSET, NY

sec.gov

Transactions

Companies

Filings

CIK

0001442372

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-16	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+2,145 sh	$66.13	+$142K	35,774
2026-06-16	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−2,145 sh	$254.00	−$545K	33,629
2026-06-16	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,145 sh	—	—	0
2026-06-05	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+836 sh	—	—	33,629
2026-06-05	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+2,938 sh	—	—	2,938
2026-03-23	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−1,000 sh	$207.87	−$208K	32,793
2026-03-03	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+2,034 sh	$69.51	+$141K	35,827
2026-03-03	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−2,034 sh	$201.50	−$410K	33,793
2026-03-03	LGNDLIGAND PHARMACEUTICALS INC · Non- Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,034 sh	—	—	0
2025-06-06	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+1,209 sh	—	—	33,793
2025-06-06	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+5,783 sh	—	—	5,783
2025-04-01	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+2,406 sh	$52.30	+$126K	32,584
2025-04-01	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,406 sh	—	—	0
2024-06-14	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+1,252 sh	—	—	30,178
2024-06-14	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+5,444 sh	—	—	5,444
2024-03-05	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+2,893 sh	—	—	30,819
2024-03-05	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−1,893 sh	$74.30	−$141K	28,926
2024-03-05	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,893 sh	—	—	419
2023-06-09	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+1,142 sh	—	—	26,926
2023-06-09	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	−5,461 sh	—	—	5,461
2023-05-10	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+6,408 sh	—	—	32,192
2023-05-10	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−6,408 sh	$77.13	−$494K	25,784
2023-05-10	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,408 sh	—	—	927
2022-12-22	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+6,623 sh	—	—	6,623
2022-06-10	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+1,004 sh	—	—	26,065
2022-06-10	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	−4,340 sh	—	—	4,340
2021-06-04	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+630 sh	—	—	25,061
2021-06-04	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	−3,269 sh	—	—	3,269
2021-02-09	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+7,335 sh	$10.12	+$74.2K	31,766
2021-02-09	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+7,335 sh	$12.53	+$91.9K	39,101
2021-02-09	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−556 sh	$208.00	−$116K	38,545
2021-02-09	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−14.1K sh	$208.55	−$2.94M	24,431
2021-02-09	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,335 sh	—	—	0
2021-02-09	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,335 sh	—	—	0
2020-06-10	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+831 sh	—	—	24,431
2020-06-10	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+2,468 sh	—	—	2,468
2019-07-31	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−4,091 sh	$94.45	−$386K	23,600
2019-06-06	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+835 sh	—	—	27,691
2019-06-06	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+4,071 sh	—	—	4,071
2018-09-04	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$8.58	+$21.5K	29,356
2018-09-04	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$17.88	+$44.7K	31,856
2018-09-04	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−5,000 sh	$255.05	−$1.28M	26,856
2018-09-04	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	0
2018-09-04	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	0
2018-08-09	NOVELION THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-06-19	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+493 sh	—	—	26,856
2018-06-19	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+2,474 sh	—	—	2,474
2018-06-19	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+493 sh	—	—	26,856
2018-06-19	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+2,474 sh	—	—	2,474
2018-03-12	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−622 sh	$180.73	−$112K	26,363

Recent filings

Accepted (ET)
Jun 184
Sabba Stephen L0001104659-26-075456
SEC(opens sec.gov)
Jun 94
Sabba Stephen L0002001011-26-000100
SEC(opens sec.gov)
Mar 254
Sabba Stephen L0001104659-26-034308
SEC(opens sec.gov)
Mar 54
Sabba Stephen L0001104659-26-023943
SEC(opens sec.gov)
Jun 104
Sabba Stephen L0002001011-25-000042
SEC(opens sec.gov)
Apr 164
Sabba Stephen L0001104659-25-035352
SEC(opens sec.gov)
Jun 254
Sabba Stephen L0002001011-24-000061
SEC(opens sec.gov)
Mar 74
Sabba Stephen L0001104659-24-031806
SEC(opens sec.gov)
Jun 214
Sabba Stephen L0001104659-23-073212
SEC(opens sec.gov)

Companies

Address

485 UNDERHILL BLVD SUITE 205

SYOSSET, NY, 11791